PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

3 of 4 are aware of ACA individual mandate; only 4 of 10 aware of marketplaces, subsidies

Commonwealth Fund survey also finds wide support for expanding Medicaid, including among low-income and uninsured Republicans

2013-09-30
(Press-News.org) New York, NY, September 30, 2013—As the key components of the Affordable Care Act roll out this week, more than three-quarters (76%) of U.S. adults are aware of the law's individual mandate, while only four of 10 are aware of the new health insurance marketplaces opening on October 1, or the financial assistance that is available to help people with low or moderate incomes pay their health insurance premiums, according to a new Commonwealth Fund survey. It also finds broad support for expanding Medicaid in all states, with 68 percent of adults saying they are somewhat or strongly in favor of making Medicaid available to more residents in their state.

The Commonwealth Fund Health Insurance Marketplace Survey, conducted between July and September of this year, is part of the foundation's efforts to track implementation of the health reform law. It finds that the people most likely to benefit from the health insurance marketplaces and premium subsidies are often least likely to be aware of them. According to the report based on the survey, What Americans Think of the New Insurance Marketplaces and Medicaid Expansion:

Only 32 percent of people without health coverage during the past year are aware of the marketplaces, compared to 43 percent of people with coverage all year. Thirty-one percent of people without coverage during the year are aware of the subsidies that are available, compared to 43 percent of those insured all year. Just under one-third (32%) of adults with incomes under 250 percent of the federal poverty level ($28,725 for an individual and $58,875 for a family) are aware of the subsidies, compared to 47 percent of those with higher incomes.

The survey finds that once people are made aware of the marketplaces, 61 percent of those who are potentially eligible—because they were either uninsured at the time of the survey or had purchased an individual insurance plan—said they are very or somewhat likely to shop for coverage in the marketplaces. However, only a slight majority of young adults (55%) ages 19 to 29 who are potentially eligible for the coverage options said they are very or somewhat likely to use the marketplaces, compared to 65 percent of those ages 30 to 49.

Potentially eligible adults with health problems were slightly more likely to say they would use the marketplaces than adults with no health problems (65% vs. 57%). Nearly equal shares of potentially eligible people who identify themselves as Democrats or Republicans said they are very or somewhat likely to shop in the marketplaces (67% vs. 63%), though Democrats express somewhat stronger interest.

"These survey findings demonstrate that people who need the health insurance coverage the marketplaces will offer want to shop for plans and find out if they are eligible for financial help," said Commonwealth Fund vice president Sara Collins, Ph.D., the study's lead author. "However, more work needs to be done to ensure that people who may be eligible are aware of the marketplaces and the subsidies. State and federal efforts to educate people about the marketplaces during the six-month enrollment period beginning in October need to be intensive enough to help close the information gaps this survey highlights."

Support for Medicaid Expansion Despite the fact that only 25 states and the District of Columbia have agreed to expand Medicaid under the Affordable Care Act, strong majorities of Americans support doing so. Across the country, 68 percent of adults are somewhat or strongly in favor of making Medicaid available to more residents in their state. The report also finds that:

Seventy-eight percent of people without insurance for a time during the past year, and 82 percent of people earning less than $32,499 a year for a family of four, support expanding Medicaid to more people in their state. Ninety-one percent of uninsured Democrats, 78 percent of uninsured Independents, and 73 percent of uninsured Republicans strongly or somewhat favor their state making Medicaid available to more residents. Ninety percent of Democrats, 79 percent of Independents, and 75 percent of Republicans making less than $32,499 a year for a family of four are in favor of making Medicaid available to more people.

While 85 percent of adults surveyed do not know what their state has decided regarding the Medicaid expansion, among those who do, two-thirds (68%) of those who are aware their state is expanding Medicaid are in favor of that decision. Only 38 percent of adults who know their state is not expanding Medicaid are strongly or somewhat in favor of their state's decision.

"The strong support for expanding Medicaid is consistent with past studies showing that Americans generally like the individual components of the Affordable Care Act when they understand them," said Commonwealth Fund president David Blumenthal, M.D. "This study also shows that there is a great deal of work to be done to ensure that Americans have a clear, accurate view of the law and what it offers the American people."

### Additional Survey Findings: Just under half (47%) of adults are aware that health insurance carriers are banned from denying coverage to people with a preexisting condition, or from charging them more money or refusing to cover a condition in their policy. Sixty-five percent of those ages 30 to 49 and 62 percent of those ages 50 to 64 who are potentially eligible for the coverage options said they are likely to use the marketplaces.


ELSE PRESS RELEASES FROM THIS DATE:

Anti-cancer drug T-DM1 benefits women with advanced breast cancer who've failed previous treatments

2013-09-28
Amsterdam, The Netherlands: First results from a phase III clinical trial of the combination drug, T-DM1, show that it significantly improves the length of time before the disease worsens in women with advanced HER2 positive breast cancer whose cancer has recurred or progressed despite previous treatments, including trastuzumab and lapatinib. In a late-breaking presentation to the 2013 European Cancer Congress (ECC2013) [1] today (Saturday), Professor Hans Wildiers will say: "This study shows that even in heavily pre-treated women, 75% of whom had cancer that has spread ...

Longest follow-up of melanoma patients treated with ipilimumab shows some survive up to 10 years

2013-09-28
Patients with advanced melanoma, who have been treated with the monoclonal antibody, ipilimumab, can survive for up to ten years, according to the largest analysis of overall survival for these patients, presented at the 2013 European Cancer Congress (ECC2013) [1] today (Saturday). Professor Stephen Hodi (MD), Assistant Professor of Medicine at the Dana-Farber Cancer Institute (Boston, USA), told the congress: "Our findings demonstrate that there is a plateau in overall survival, which begins around the third year and extends through to the tenth year. "These results ...

Treating chest lymph nodes in early breast cancer patients improves survival

2013-09-28
Giving radiation therapy to the lymph nodes located behind the breast bone and above the collar bone to patients with early breast cancer improves overall survival without increasing side effects. This new finding ends the uncertainty about whether the beneficial effect of radiation therapy in such patients was simply the result of irradiation of the breast area, or whether it treated cancer cells in the local lymph nodes as well, the 2013 European Cancer Congress (ECC2013) [1] will hear today (Saturday). Dr Philip Poortmans, a radiation oncologist from the Institute ...

Hyperfractionated radiotherapy improves survival in head and neck cancer patients

2013-09-28
The use of an intensified form of radiotherapy in patients with locally advanced head and neck cancers can improve overall survival rates compared with standard radiation therapy, according to results from a large study to be presented today (Saturday) at the 2013 European Cancer Congress (ECC2013) [1]. A comparison of altered fractionation radiotherapy (AFRT) with standard fractionation radiotherapy (SFRT) in a meta-analysis of more than 11,000 patients showed an eight percent reduction in the risk of death in the AFRT group, as well as a nine percent reduction in the ...

Researchers demonstrate 'accelerator on a chip'

2013-09-28
In an advance that could dramatically shrink particle accelerators for science and medicine, researchers used a laser to accelerate electrons at a rate 10 times higher than conventional technology in a nanostructured glass chip smaller than a grain of rice. The achievement was reported today in Nature by a team including scientists from the U.S. Department of Energy's (DOE) SLAC National Accelerator Laboratory and Stanford University. "We still have a number of challenges before this technology becomes practical for real-world use, but eventually it would substantially ...

Survival after cancer diagnosis in Europe associated with amount governments spend on health care

2013-09-28
The more an EU (European Union) national government spends on health, the fewer the deaths after a cancer diagnosis in that country, according to new research to be presented to the 2013 European Cancer Congress (ECC2013) [1] today (Sunday) and published simultaneously in the leading cancer journal Annals of Oncology [2]. Researchers will tell the meeting that higher wealth and higher health expenditure are strongly associated both with increased cancer incidence and decreased cancer mortality. In the case of breast cancer, increased health expenditure appears to be ...

Colorectal cancer screening works

2013-09-28
Screening for colorectal cancer (CRC) in European countries is highly effective in reducing mortality from the disease. Some of the resources currently being devoted to breast and prostate screening programmes, where the evidence of effectiveness is much less clear-cut, should be reallocated to the early detection of CRC, the 2013 European Cancer Congress (ECC2013) [1] will hear today (Sunday). Professor Philippe Autier, Vice President, Population Studies, at the International Prevention Research Institute, Lyon, France, will report on results extracted from data on CRC ...

Diabetes increases the risk of developing and dying from breast and colon cancer

2013-09-28
Diabetes is linked to an increased risk of developing cancer, and now researchers have performed a unique meta-analysis that excludes all other causes of death and found that diabetic patients not only have an increased risk of developing breast and colon cancer but an even higher risk of dying from them. Dr Kirstin De Bruijn will tell the 2013 European Cancer Congress (ECC2013) [1], today (Sunday), that previous studies have examined the association between diabetes and dying from cancer but death from specific types of cancer has not been well-studied. "Our meta-analysis ...

Young patients with metastatic colorectal cancer are at high risk of disease progression and death

2013-09-28
Younger patients with colorectal cancer that has spread (metastasised) to other parts of the body represent a high-risk group that is less likely to respond to anti-cancer treatments. Their disease is more likely to progress and they are at greater risk of death than other age groups, according to new research to be presented to the 2013 European Cancer Congress (ECC2013) [1] today (Sunday). An analysis of 20,034 patients in 24 phase III clinical trials [2] for colorectal cancer, of which 695 patients (3%) were younger than 40, showed that the youngest and oldest patients ...

Everolimus slows disease progression in advanced papillary kidney cancer patients

2013-09-28
The first Phase II study to investigate the use of the anti-cancer drug, everolimus, for the initial treatment of advanced papillary kidney cancer has shown that it is successful in slowing or preventing the spread of the disease, according to research to be presented today (Sunday) at the 2013 European Cancer Congress (ECC2013) [1]. Dr Bernard Escudier, Head of the French Group of Immunotherapy and chairman of the Genitourinary tumour board at the Institut Gustave Roussy in Villejuif, France will say: "Our results showed that for 59% of patients who received everolimus ...

LAST 30 PRESS RELEASES:

Mega-iceberg from Antarctica on collision course with South Georgia: harbinger of things to come?

Beneath the bog: FAU awarded $1.3 million to track carbon and gas flow in peatlands

ETRI to collaborate on semiconductor technology with US Argonne National Laboratory

Unexpected discoveries in study of giraffe gut flora

Not all heart inflammation is the same

New home-based intervention could reduce emergency hospital admissions for older people

Can exercise help colon cancer survivors live as long as matched individuals in the general population?

Unlicensed retailers provide youths with easy access to cannabis in New York City

Scientists track evolution of pumice rafts after 2021 underwater eruption in Japan

The future of geothermal for reliable clean energy

Study shows end-of-life cancer care lacking for Medicare patients

Scented wax melts may not be as safe for indoor air as initially thought, study finds

Underwater mics and machine learning aid right whale conservation

Solving the case of the missing platinum

Glass fertilizer beads could be a sustained nutrient delivery system

Biobased lignin gels offer sustainable alternative for hair conditioning

Perovskite solar cells: Thermal stresses are the key to long-term stability

University of Houston professors named senior members of the National Academy of Inventors

Unraveling the mystery of the missing blue whale calves

UTA partnership boosts biomanufacturing in North Texas

Kennesaw State researcher earns American Heart Association award for innovative study on heart disease diagnostics

Self-imaging of structured light in new dimensions

Study highlights successes of Virginia’s oyster restoration efforts

Optimism can encourage healthy habits

Precision therapy with microbubbles

LLM-based web application scanner recognizes tasks and workflows

Pattern of compounds in blood may indicate severity of gestational hypertension and preeclampsia

How does innovation policy respond to the challenges of a changing world?

What happens when a diet targets ultra-processed foods?

University of Vaasa, Finland, conducts research on utilizing buildings as energy sources

[Press-News.org] 3 of 4 are aware of ACA individual mandate; only 4 of 10 aware of marketplaces, subsidies
Commonwealth Fund survey also finds wide support for expanding Medicaid, including among low-income and uninsured Republicans